CD8A and neoplasm: Microbial transformations of primary bile acids into secondary bile acids (e.g., DCA, LCA) perturb host metabolic and immune signaling via receptors such as FXR and TGR5, thereby promoting tumor-friendly inflammation, immune-evasion (notably CD8+ T cell suppression) and fibrogenic/malignant progression (156).